Yagin, F.H.; Gormez, Y.; Colak, C.; Algarni, A.; Al-Hashem, F.; Ardigò, L.P.
Precision Enhanced Bioactivity Prediction of Tyrosine Kinase Inhibitors by Integrating Deep Learning and Molecular Fingerprints Towards Cost-Effective and Targeted Cancer Therapy. Pharmaceuticals 2025, 18, 975.
https://doi.org/10.3390/ph18070975
AMA Style
Yagin FH, Gormez Y, Colak C, Algarni A, Al-Hashem F, Ardigò LP.
Precision Enhanced Bioactivity Prediction of Tyrosine Kinase Inhibitors by Integrating Deep Learning and Molecular Fingerprints Towards Cost-Effective and Targeted Cancer Therapy. Pharmaceuticals. 2025; 18(7):975.
https://doi.org/10.3390/ph18070975
Chicago/Turabian Style
Yagin, Fatma Hilal, Yasin Gormez, Cemil Colak, Abdulmohsen Algarni, Fahaid Al-Hashem, and Luca Paolo Ardigò.
2025. "Precision Enhanced Bioactivity Prediction of Tyrosine Kinase Inhibitors by Integrating Deep Learning and Molecular Fingerprints Towards Cost-Effective and Targeted Cancer Therapy" Pharmaceuticals 18, no. 7: 975.
https://doi.org/10.3390/ph18070975
APA Style
Yagin, F. H., Gormez, Y., Colak, C., Algarni, A., Al-Hashem, F., & Ardigò, L. P.
(2025). Precision Enhanced Bioactivity Prediction of Tyrosine Kinase Inhibitors by Integrating Deep Learning and Molecular Fingerprints Towards Cost-Effective and Targeted Cancer Therapy. Pharmaceuticals, 18(7), 975.
https://doi.org/10.3390/ph18070975
